Clinical Trial Detail

NCT ID NCT02613650
Title A Trial of FOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors University of Utah
Indications

colorectal cancer

Therapies

Binimetinib + Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult

Additional content available in CKB BOOST